Literature DB >> 12836090

Familial Mediterranean fever.

Aysin Bakkaloglu1.   

Abstract

Familial Mediterranean fever (FMF) is the most frequent periodic syndrome characterized by recurrent attacks of polyserositis. Fever, abdominal pain, chest pain, and arthritis/arthralgia are the leading symptoms. It is an autosomal recessive disorder, which primarily affects Jewish, Armenian, Turkish, and Arab populations. The FMF gene ( MEFV) has recently been cloned to chromosome 16p, which encodes pyrin. Genotype-phenotype correlation is not well established. Amyloidosis is the most severe complication of FMF. The SAA1-alpha/alpha genotype was associated with an increased risk of amyloidosis. Colchicine treatment not only decreases the frequency and severity of attacks, but also prevents amyloidosis. Certain vasculitides, namely Henoch-Schonlein purpura and polyarteritis nodosa, are more frequent among FMF patients.

Entities:  

Mesh:

Year:  2003        PMID: 12836090     DOI: 10.1007/s00467-003-1185-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  72 in total

1.  Acute phase response and evolution of familial Mediterranean fever.

Authors:  M Tunca; G Kirkali; M Soytürk; S Akar; M B Pepys; P N Hawkins
Journal:  Lancet       Date:  1999-04-24       Impact factor: 79.321

2.  [Five cases of periodic disease].

Authors:  S ARTUNKAL; V SEYAHI
Journal:  Turk Tip Cemiy Mecm       Date:  1955-06

3.  Rapid progressive glomerulonephritis in patients with familial Mediterranean fever.

Authors:  R Said; Y Hamzeh; M Tarawneh; M el-Khateeb; M Abdeen; A Shaheen
Journal:  Am J Kidney Dis       Date:  1989-11       Impact factor: 8.860

4.  [Circulating immune complexes in familial Mediterranean fever, systemic lupus erythematosus and HBsAg carriers].

Authors:  A Zlotnick; Y Levo; R Fishel; M Ehrenfeld; M Levy; D Shouval; M Eliakin
Journal:  Harefuah       Date:  1979-08

5.  MEFV mutations and phenotype-genotype correlations in North African Jews and Armenians with familial Mediterranean fever.

Authors:  D Cattan; M Dervichian; M Thomas; C Dode; I Touitou
Journal:  Isr Med Assoc J       Date:  2001-11       Impact factor: 0.892

6.  Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium.

Authors: 
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

7.  Allogeneic bone marrow transplantation: cure for familial Mediterranean fever.

Authors:  John Milledge; Peter J Shaw; Albert Mansour; Sarah Williamson; Bruce Bennetts; Tony Roscioli; Julie Curtin; John Christodoulou
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

8.  Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever.

Authors:  A Duzova; A Bakkaloglu; N Besbas; R Topaloglu; S Ozen; F Ozaltin; Y Bassoy; E Yilmaz
Journal:  Clin Exp Rheumatol       Date:  2003 Jul-Aug       Impact factor: 4.473

9.  Evolutionary study of multigenic families mapping close to the human MHC class I region.

Authors:  C Vernet; J Boretto; M G Mattéi; M Takahashi; L J Jack; I H Mather; S Rouquier; P Pontarotti
Journal:  J Mol Evol       Date:  1993-12       Impact factor: 2.395

10.  Unusual immunologic findings in familial Mediterranean fever.

Authors:  M Savi; G Asinari; V Gaudiano; G Olivetti; T M Neri
Journal:  Arch Intern Med       Date:  1978-04
View more
  24 in total

1.  Structural and functional insights into the B30.2/SPRY domain.

Authors:  Jae-Sung Woo; Joon-Hyuk Imm; Chang-Ki Min; Kyung-Jin Kim; Sun-Shin Cha; Byung-Ha Oh
Journal:  EMBO J       Date:  2006-02-23       Impact factor: 11.598

2.  Evaluation of subclinical inflammation in familial Mediterranean fever patients: relations with mutation types and attack status: a retrospective study.

Authors:  Fatih Mehmet Kelesoglu; Erhan Aygun; Nazli Kubra Okumus; Ayşenur Ersoy; Edanur Karapınar; Nesibe Saglam; Nur Gokce Aydın; Beyza Betul Senay; Sumeyye Gonultas; Elif Sarisik; Melike Zeynep Can; Sirin Atay; Dilruba Basbug; Feyza Kubra Tiryaki; Sena Ozer; Rana Berru Durmus; Fatih Orem; Tugrul Atay; Ahmet Acar; Yasin Yilmaz; Seyma Kaya; Aylin Ciftkaya; Zeynep Sarac; Cagri Can Makar; Basak Saracoglu; Gafur Dogdu; Rukiye Eker Omeroglu
Journal:  Clin Rheumatol       Date:  2016-04-23       Impact factor: 2.980

3.  Plasminogen activator inhibitor-1 gene polymorphism in Iranian Azeri Turkish patients with FMF disease and its association with amyloidosis.

Authors:  M Bonyadi; Z Shaghaghi; M Haghi; S Dastgiri
Journal:  Eur J Pediatr       Date:  2012-10-05       Impact factor: 3.183

4.  QT dispersion in uncomplicated familial Mediterranean fever.

Authors:  Naomi Nussinovitch; Avi Livneh; Keren Katz; Pnina Langevitz; Olga Feld; Moshe Nussinovitch; Benjamin Volovitz; Merav Lidar; Udi Nussinovitch
Journal:  Clin Rheumatol       Date:  2010-04-11       Impact factor: 2.980

5.  Rubinstein-Taybi syndrome and familial Mediterranean fever in a single patient: two distinct genetic diseases located on chromosome 16p13.3.

Authors:  Umut Kalyoncu; Abdurrahman Tufan; Omer Karadag; Bunyamin Kisacik; Ali Akdogan; Meral Calguneri
Journal:  J Natl Med Assoc       Date:  2006-10       Impact factor: 1.798

6.  Investigation of the Levels of Serum Amyloid A, YKL-40, and Pentraxin-3 in Patients with Familial Mediterranean Fever.

Authors:  Sefa Ciftci; Huseyin Tugrul Celik; Pinar Atukeren; Nurdan Ciftci; Mustafa Saygin Deniz; Yasemin Coskun Yavuz; Fatmanur Hacievliyagil Kazanci; Sümeyye Gök; Hilmi Demirin; Muhammet Ramazan Yigitoglu
Journal:  J Clin Lab Anal       Date:  2016-05-26       Impact factor: 2.352

7.  The effect of colchicine and disease severity on physical growth in children with familial Mediterranean fever.

Authors:  Tuba Çelen Yoldaş; Nilgün Çakar; Özge Başaran; Banu Acar; Nermin Uncu; F Şemsa Çaycı
Journal:  Clin Rheumatol       Date:  2015-09-18       Impact factor: 2.980

8.  Bone mineral density in patients with familial Mediterranean fever.

Authors:  Kadir Yildirim; Saliha Karatay; Ramazan Cetinkaya; Hulya Uzkeser; Akin Erdal; Ilyas Capoglu; Fazile Hatipoglu Erdem
Journal:  Rheumatol Int       Date:  2009-05-16       Impact factor: 2.631

Review 9.  Ubiquitous SPRY domains and their role in the skeletal type ryanodine receptor.

Authors:  Hanshen Tae; Marco G Casarotto; Angela Fay Dulhunty
Journal:  Eur Biophys J       Date:  2009-04-28       Impact factor: 1.733

10.  Evaluation of intima media thickness of the common and internal carotid arteries with inflammatory markers in familial Mediterranean fever as possible predictors for atherosclerosis.

Authors:  Yelda Bilginer; Fatih Ozaltin; Ceyla Basaran; Ali Duzova; Nesrin Besbas; Rezan Topaloglu; Seza Ozen; Aysin Bakkaloglu
Journal:  Rheumatol Int       Date:  2008-05-24       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.